List of Tables
Table 1. Global Lymphocyte Activation Gene 3 Protein Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Lymphocyte Activation Gene 3 Protein Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Lymphocyte Activation Gene 3 Protein Market Competitive Situation by Manufacturers in 2024
Table 4. Global Lymphocyte Activation Gene 3 Protein Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Lymphocyte Activation Gene 3 Protein Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Lymphocyte Activation Gene 3 Protein Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Lymphocyte Activation Gene 3 Protein Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Lymphocyte Activation Gene 3 Protein Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Lymphocyte Activation Gene 3 Protein, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Lymphocyte Activation Gene 3 Protein, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Lymphocyte Activation Gene 3 Protein, Product Type & Application
Table 12. Global Key Manufacturers of Lymphocyte Activation Gene 3 Protein, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lymphocyte Activation Gene 3 Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lymphocyte Activation Gene 3 Protein as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Lymphocyte Activation Gene 3 Protein Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Lymphocyte Activation Gene 3 Protein Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Lymphocyte Activation Gene 3 Protein Sales Market Share by Region (2020-2025)
Table 19. Global Lymphocyte Activation Gene 3 Protein Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Lymphocyte Activation Gene 3 Protein Sales Market Share by Region (2026-2031)
Table 21. Global Lymphocyte Activation Gene 3 Protein Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Lymphocyte Activation Gene 3 Protein Revenue Market Share by Region (2020-2025)
Table 23. Global Lymphocyte Activation Gene 3 Protein Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Lymphocyte Activation Gene 3 Protein Revenue Market Share by Region (2026-2031)
Table 25. North America Lymphocyte Activation Gene 3 Protein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Lymphocyte Activation Gene 3 Protein Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Lymphocyte Activation Gene 3 Protein Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Lymphocyte Activation Gene 3 Protein Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Lymphocyte Activation Gene 3 Protein Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Lymphocyte Activation Gene 3 Protein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Lymphocyte Activation Gene 3 Protein Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Lymphocyte Activation Gene 3 Protein Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Lymphocyte Activation Gene 3 Protein Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Lymphocyte Activation Gene 3 Protein Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Lymphocyte Activation Gene 3 Protein Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Lymphocyte Activation Gene 3 Protein Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Lymphocyte Activation Gene 3 Protein Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Lymphocyte Activation Gene 3 Protein Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Lymphocyte Activation Gene 3 Protein Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Lymphocyte Activation Gene 3 Protein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Lymphocyte Activation Gene 3 Protein Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Lymphocyte Activation Gene 3 Protein Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Lymphocyte Activation Gene 3 Protein Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Lymphocyte Activation Gene 3 Protein Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Lymphocyte Activation Gene 3 Protein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Lymphocyte Activation Gene 3 Protein Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Lymphocyte Activation Gene 3 Protein Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Lymphocyte Activation Gene 3 Protein Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Lymphocyte Activation Gene 3 Protein Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Lymphocyte Activation Gene 3 Protein Sales (K Pcs) by Type (2020-2025)
Table 51. Global Lymphocyte Activation Gene 3 Protein Sales (K Pcs) by Type (2026-2031)
Table 52. Global Lymphocyte Activation Gene 3 Protein Sales Market Share by Type (2020-2025)
Table 53. Global Lymphocyte Activation Gene 3 Protein Sales Market Share by Type (2026-2031)
Table 54. Global Lymphocyte Activation Gene 3 Protein Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Lymphocyte Activation Gene 3 Protein Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Lymphocyte Activation Gene 3 Protein Revenue Market Share by Type (2020-2025)
Table 57. Global Lymphocyte Activation Gene 3 Protein Revenue Market Share by Type (2026-2031)
Table 58. Global Lymphocyte Activation Gene 3 Protein Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Lymphocyte Activation Gene 3 Protein Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Lymphocyte Activation Gene 3 Protein Sales (K Pcs) by Application (2020-2025)
Table 61. Global Lymphocyte Activation Gene 3 Protein Sales (K Pcs) by Application (2026-2031)
Table 62. Global Lymphocyte Activation Gene 3 Protein Sales Market Share by Application (2020-2025)
Table 63. Global Lymphocyte Activation Gene 3 Protein Sales Market Share by Application (2026-2031)
Table 64. Global Lymphocyte Activation Gene 3 Protein Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Lymphocyte Activation Gene 3 Protein Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Lymphocyte Activation Gene 3 Protein Revenue Market Share by Application (2020-2025)
Table 67. Global Lymphocyte Activation Gene 3 Protein Revenue Market Share by Application (2026-2031)
Table 68. Global Lymphocyte Activation Gene 3 Protein Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Lymphocyte Activation Gene 3 Protein Price (USD/Pcs) by Application (2026-2031)
Table 70. Boehringer Ingelheim GmbH Company Information
Table 71. Boehringer Ingelheim GmbH Description and Business Overview
Table 72. Boehringer Ingelheim GmbH Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Boehringer Ingelheim GmbH Lymphocyte Activation Gene 3 Protein Product
Table 74. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 75. Bristol-Myers Squibb Company Company Information
Table 76. Bristol-Myers Squibb Company Description and Business Overview
Table 77. Bristol-Myers Squibb Company Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Bristol-Myers Squibb Company Lymphocyte Activation Gene 3 Protein Product
Table 79. Bristol-Myers Squibb Company Recent Developments/Updates
Table 80. Crescendo Biologics Ltd Company Information
Table 81. Crescendo Biologics Ltd Description and Business Overview
Table 82. Crescendo Biologics Ltd Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Crescendo Biologics Ltd Lymphocyte Activation Gene 3 Protein Product
Table 84. Crescendo Biologics Ltd Recent Developments/Updates
Table 85. Enumeral Biomedical Holdings Inc Company Information
Table 86. Enumeral Biomedical Holdings Inc Description and Business Overview
Table 87. Enumeral Biomedical Holdings Inc Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Enumeral Biomedical Holdings Inc Lymphocyte Activation Gene 3 Protein Product
Table 89. Enumeral Biomedical Holdings Inc Recent Developments/Updates
Table 90. GlaxoSmithKline Plc Company Information
Table 91. GlaxoSmithKline Plc Description and Business Overview
Table 92. GlaxoSmithKline Plc Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. GlaxoSmithKline Plc Lymphocyte Activation Gene 3 Protein Product
Table 94. GlaxoSmithKline Plc Recent Developments/Updates
Table 95. Icell Kealex Therapeutics Company Information
Table 96. Icell Kealex Therapeutics Description and Business Overview
Table 97. Icell Kealex Therapeutics Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Icell Kealex Therapeutics Lymphocyte Activation Gene 3 Protein Product
Table 99. Icell Kealex Therapeutics Recent Developments/Updates
Table 100. Incyte Corp Company Information
Table 101. Incyte Corp Description and Business Overview
Table 102. Incyte Corp Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Incyte Corp Lymphocyte Activation Gene 3 Protein Product
Table 104. Incyte Corp Recent Developments/Updates
Table 105. MacroGenics Inc Company Information
Table 106. MacroGenics Inc Description and Business Overview
Table 107. MacroGenics Inc Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. MacroGenics Inc Lymphocyte Activation Gene 3 Protein Product
Table 109. MacroGenics Inc Recent Developments/Updates
Table 110. Merck & Co Inc Company Information
Table 111. Merck & Co Inc Description and Business Overview
Table 112. Merck & Co Inc Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Merck & Co Inc Lymphocyte Activation Gene 3 Protein Product
Table 114. Merck & Co Inc Recent Developments/Updates
Table 115. Novartis AG Company Information
Table 116. Novartis AG Description and Business Overview
Table 117. Novartis AG Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Novartis AG Lymphocyte Activation Gene 3 Protein Product
Table 119. Novartis AG Recent Developments/Updates
Table 120. Prima BioMed Ltd Company Information
Table 121. Prima BioMed Ltd Description and Business Overview
Table 122. Prima BioMed Ltd Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Prima BioMed Ltd Lymphocyte Activation Gene 3 Protein Product
Table 124. Prima BioMed Ltd Recent Developments/Updates
Table 125. Regeneron Pharmaceuticals Inc Company Information
Table 126. Regeneron Pharmaceuticals Inc Description and Business Overview
Table 127. Regeneron Pharmaceuticals Inc Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Regeneron Pharmaceuticals Inc Lymphocyte Activation Gene 3 Protein Product
Table 129. Regeneron Pharmaceuticals Inc Recent Developments/Updates
Table 130. Sutro Biopharma Inc Company Information
Table 131. Sutro Biopharma Inc Description and Business Overview
Table 132. Sutro Biopharma Inc Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Sutro Biopharma Inc Lymphocyte Activation Gene 3 Protein Product
Table 134. Sutro Biopharma Inc Recent Developments/Updates
Table 135. Symphogen A/S Company Information
Table 136. Symphogen A/S Description and Business Overview
Table 137. Symphogen A/S Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Symphogen A/S Lymphocyte Activation Gene 3 Protein Product
Table 139. Symphogen A/S Recent Developments/Updates
Table 140. Tesaro Inc Company Information
Table 141. Tesaro Inc Description and Business Overview
Table 142. Tesaro Inc Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. Tesaro Inc Lymphocyte Activation Gene 3 Protein Product
Table 144. Tesaro Inc Recent Developments/Updates
Table 145. Trellis Bioscience Inc Company Information
Table 146. Trellis Bioscience Inc Description and Business Overview
Table 147. Trellis Bioscience Inc Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. Trellis Bioscience Inc Lymphocyte Activation Gene 3 Protein Product
Table 149. Trellis Bioscience Inc Recent Developments/Updates
Table 150. Xencor Inc Company Information
Table 151. Xencor Inc Description and Business Overview
Table 152. Xencor Inc Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 153. Xencor Inc Lymphocyte Activation Gene 3 Protein Product
Table 154. Xencor Inc Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Lymphocyte Activation Gene 3 Protein Distributors List
Table 158. Lymphocyte Activation Gene 3 Protein Customers List
Table 159. Lymphocyte Activation Gene 3 Protein Market Trends
Table 160. Lymphocyte Activation Gene 3 Protein Market Drivers
Table 161. Lymphocyte Activation Gene 3 Protein Market Challenges
Table 162. Lymphocyte Activation Gene 3 Protein Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Lymphocyte Activation Gene 3 Protein
Figure 2. Global Lymphocyte Activation Gene 3 Protein Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Lymphocyte Activation Gene 3 Protein Market Share by Type: 2024 & 2031
Figure 4. BMS-986016 Product Picture
Figure 5. ENUM-006 Product Picture
Figure 6. IKT-203 Product Picture
Figure 7. IMP-701 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Lymphocyte Activation Gene 3 Protein Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Lymphocyte Activation Gene 3 Protein Market Share by Application: 2024 & 2031
Figure 11. Chronic Inflammation
Figure 12. Head and Neck Cancer Squamous Cell Carcinoma
Figure 13. Kidney Cancer
Figure 14. Others
Figure 15. Global Lymphocyte Activation Gene 3 Protein Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Lymphocyte Activation Gene 3 Protein Market Size (2020-2031) & (US$ Million)
Figure 17. Global Lymphocyte Activation Gene 3 Protein Sales (2020-2031) & (K Pcs)
Figure 18. Global Lymphocyte Activation Gene 3 Protein Average Price (USD/Pcs) & (2020-2031)
Figure 19. Lymphocyte Activation Gene 3 Protein Report Years Considered
Figure 20. Lymphocyte Activation Gene 3 Protein Sales Share by Manufacturers in 2024
Figure 21. Global Lymphocyte Activation Gene 3 Protein Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Lymphocyte Activation Gene 3 Protein Players: Market Share by Revenue in Lymphocyte Activation Gene 3 Protein in 2024
Figure 23. Lymphocyte Activation Gene 3 Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Lymphocyte Activation Gene 3 Protein Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Lymphocyte Activation Gene 3 Protein Sales Market Share by Country (2020-2031)
Figure 26. North America Lymphocyte Activation Gene 3 Protein Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Lymphocyte Activation Gene 3 Protein Sales Market Share by Country (2020-2031)
Figure 30. Europe Lymphocyte Activation Gene 3 Protein Revenue Market Share by Country (2020-2031)
Figure 31. Germany Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Lymphocyte Activation Gene 3 Protein Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Lymphocyte Activation Gene 3 Protein Revenue Market Share by Region (2020-2031)
Figure 38. China Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Taiwan Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Philippines Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Lymphocyte Activation Gene 3 Protein Sales Market Share by Country (2020-2031)
Figure 49. Latin America Lymphocyte Activation Gene 3 Protein Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Lymphocyte Activation Gene 3 Protein Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Lymphocyte Activation Gene 3 Protein Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Lymphocyte Activation Gene 3 Protein Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Lymphocyte Activation Gene 3 Protein by Type (2020-2031)
Figure 59. Global Revenue Market Share of Lymphocyte Activation Gene 3 Protein by Type (2020-2031)
Figure 60. Global Lymphocyte Activation Gene 3 Protein Price (USD/Pcs) by Type (2020-2031)
Figure 61. Global Sales Market Share of Lymphocyte Activation Gene 3 Protein by Application (2020-2031)
Figure 62. Global Revenue Market Share of Lymphocyte Activation Gene 3 Protein by Application (2020-2031)
Figure 63. Global Lymphocyte Activation Gene 3 Protein Price (USD/Pcs) by Application (2020-2031)
Figure 64. Lymphocyte Activation Gene 3 Protein Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
